ARTICLE | Clinical News
CAM2029 regulatory update
August 3, 2009 7:00 AM UTC
The EC granted Orphan Drug designation for CAM2029 to treat acromegaly. The long-acting octreotide chloride lipid depot solution delivered using the company's FluidCrystal Injection depot technology i...